UK Companies House feature
LOOMIS PHARMA (UK) LIMITED
Profile
- Company number
- 14318695
- Status
- Active
- Incorporation
- 2022-08-25
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 49410
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are satisfied that Loomis AB has the necessary financial resources to provide support, should it be required. A letter of support has been signed by the parent company Loomis AB confirming their continuing support for a period of not less than 12 months from the date of approval to these financial statements.”
Significant events
- “The company was incorporated on 25 August 2022 and has not yet commenced trading as at the balance sheet date.”
- “The company has been incorporated with the view to entering into worldwide transportation of Pharma and healthcare supplies, including medical CBD, controlled drugs and temperature-controlled medications.”
- “The company did not trade in the current period. It is planned to be operational within the next 12 months. The company has in place signed contracts for both secure transport and non-secure transport.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ASLUND, Erik Daniel | Director | 2022-08-25 | Aug 1982 | Swedish |
| DEAR, Benjamin Michael | Director | 2024-02-22 | Jun 1978 | British |
| KAZES, Stephane | Director | 2022-08-25 | Jun 1979 | French |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Loomis Ab | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-08-25 | Active |
Filing timeline
Last 11 of 11 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-31 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-10-02 | AA | accounts | accounts with accounts type full |
| 2025-05-01 | AD01 | address | change registered office address company with date old address new address |
| 2025-01-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-05-29 | AA | accounts | accounts with accounts type full |
| 2024-02-22 | AP01 | officers | appoint person director company with name date |
| 2024-02-21 | AD01 | address | change registered office address company with date old address new address |
| 2024-01-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-01-04 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-09-13 | AA01 | accounts | change account reference date company current extended |
| 2022-08-25 | NEWINC | incorporation | incorporation company |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory